Page 1952 - Cote clinical veterinary advisor dogs and cats 4th
P. 1952

Thyroid Neoplasia  976.e1


           ADDITIONAL SUGGESTED                RELATED CLIENT EDUCATION
           READINGS                            SHEETS
  VetBooks.ir  Broome MR, et al: Clinical features and treatment   Consent  to  Perform  Fine-Needle  Aspiration      Diseases and   Disorders
            outcomes of 41 dogs with sublingual ectopic thyroid
                                                of Masses
            neoplasia. J Vet Intern Med 28:1560-1568, 2014.
           Campos M, et al: Clinical, pathologic, and immu-
            nohistochemical prognostic factors in dogs with   Consent to Perform Radiography
            thyroid carcinoma. J Vet Intern Med 28:1805-1813,
            2014.
           Campos  M,  et  al:  Upregulation  of  the  PI3K/Akt
            pathway in the tumorigenesis of canine thyroid
            carcinoma. J Vet Intern Med 28:1814-1823, 2014.
           Carver JR, et al: A comparison of medullary thyroid
            carcinoma and thyroid adenocarcinoma in dogs: a
            retrospective study of 38 cases. Vet Surg 24:315-
            319, 1995.
           Castillo V, et al: Post-surgical treatment of thyroid
            carcinoma in dogs with retinoic acid 9 cis improves
            patient outcome. Open Vet J 6:6-14, 2016.
           Leach TN,  et  al:  Prospective  trial  of  metronomic
            chlorambucil chemotherapy in dogs with naturally
            occurring cancer. Vet Comp Oncol 10:102-112,
            2012.
           London C, et al: Preliminary evidence for biologic
            activity of toceranib phosphate (Palladia®) in solid
            tumors. Vet Comp Oncol 10:194-205, 2012.
           Looney A, et al: Dietary management of hyperthyroid-
            ism in a dog. J Am Anim Hosp Assoc 53:111-118,
            2017.
           Pack  L,  et  al:  Definitive  radiation  therapy  for
            infiltrative thyroid carcinoma in dogs. Vet Radiol
            Ultrasound 42:471-474, 2001.
           Theon  AP,  et  al:  Prognostic  factors  and  patterns
            of treatment failure in dogs with unresectable
            differentiated  thyroid  carcinomas  treated  with
            megavoltage  irradiation.  J  Am  Vet Med  Assoc
            216:1775-1779, 2000.
           Turrel JM, et al: Sodium iodide I 131 treatment of
            dogs with nonresectable thyroid tumors: 39 cases
            (1990-2003). J Am Vet Med Assoc 229:542-548,
            2006.
           Urie BK, et al: Evaluation of expression and function
            of vascular endothelial growth factor receptor 2,
            platelet derived growth factor receptors-alpha and
            -beta, KIT, and RET in canine apocrine gland anal
            sac adenocarcinoma and thyroid carcinoma. BMC
            Vet Res 8:67, 2012.
                               131
           Worth AJ, et al: Radioiodide ( I) therapy for the
            treatment of canine thyroid carcinoma. Aust Vet
            J 83:208-214, 2005.




























                                                      www.ExpertConsult.com
   1947   1948   1949   1950   1951   1952   1953   1954   1955   1956   1957